Company news

Actinogen Medical Limited news in 2023

Actinogen Medical Limited's news releases, calls and decks from 2023, newest first.

View company

Actinogen receives $4.8 million R&D tax incentive rebate

November 28, 2023

Actinogen September quarterly activity report & Appendix 4C

October 15, 2023

Actinogen enhances XanaMIA Phase 2b Alzheimers trial

September 26, 2023

Actinogen closes successful $10 million rights issue offer

September 7, 2023

Actinogen FY2023 results, following the science

August 30, 2023

ACW Appendix 4E and 2023 Annual Report

August 30, 2023

ACW secures further $0.5m rights issue shortfall commitment

August 29, 2023

ACW secures shortfall commitments of $4.56m for rights issue

August 14, 2023

Entitlement Offer Prospectus

August 7, 2023

Actinogen announces $10 million rights offer

August 1, 2023

Quarterly Activity Report & Appendix 4C

July 31, 2023

ACW AD trial amendment and Clinical Science Forum slides

May 23, 2023

Appendix 4D & Half-Year Financial Statements

February 22, 2023

Decks in 2023